doi: 10.1161/hy1101.095331
(Hypertension. 2001;38:1044.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
Supplemention With Tetrahydrobiopterin Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats
From the Graduate Institute of Life Sciences (H-J.H., T-H.C.), Department of Pharmacology, National Defense Medical Center (M-H.Y.), and Department of Pharmacology, Taipei Medical University (G.X.), Taipei, Taiwan, Republic of China.
Correspondence to Mao-Hsiung Yen, Department of Pharmacology, National Defense Medical Center, PO Box 90048-504, Taipei, Taiwan, ROC. E-mail mhyen{at}ndmctsgh.edu.tw
Abstract—— It has been suggested that tetrahydrobiopterin (H4B), a cofactor of NO synthase, can reverse endothelial dysfunction caused by cardiovascular diseases, including atherosclerosis, coronary artery disease, and hypertension. Moreover, an impairment of H4B biosynthesis in spontaneously hypertensive rats (SHR) was observed. Thus, we hypothesized that the defect of the H4B synthesis system may play an important role in the development of hypertension in SHR. In the present study H4B (10 mg/kg per day IP) was used to treat SHR and Wistar-Kyoto rats (WKY) from the age of 5 through 16 weeks. Results demonstrated that chronic treatment with H4B significantly improved the impaired vascular responses to acetylcholine and suppressed the development of hypertension in SHR but did not affect WKY. The increase of inducible NO synthase expression, nitrotyrosine immunostaining, NO production, and superoxide anion formation in adult SHR were also significantly suppressed by chronic treatment with H4B. In contrast, H4B had no effect on WKY. In conclusion, this study demonstrated that H4B significantly attenuated the development of hypertension in SHR. The antihypertensive effect of H4B might be mediated through its direct antioxidant activity and/or decreasing oxygen free radical production from NO synthase, thereby reducing inducible NO synthase expression and peroxynitrite formation. Thus, the present study proposed that supplementation with H4B might be beneficial in preventing pathological conditions such as essential hypertension.
Key Words: nitric oxide synthase • peroxynitrite • rats, inbred SHR • superoxide • biopterin
This article has been cited by other articles:
 |
|
 |
|
  F. Rao, L. Zhang, and D. T. O'Connor Complex Trait Genetics: The Role of Mechanistic "Intermediate Phenotypes" and Candidate Genetic Loci J. Am. Coll. Cardiol., July 8, 2008; 52(2): 166 - 168. [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. d'Uscio and Z. S. Katusic Erythropoietin Increases Endothelial Biosynthesis of Tetrahydrobiopterin by Activation of Protein Kinase B{alpha}/Akt1 Hypertension, July 1, 2008; 52(1): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Paravicini and R. M. Touyz NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Koeners, E. E. van Faassen, S. Wesseling, M. de Sain-van der Velden, H. A. Koomans, B. Braam, and J. A. Joles Maternal Supplementation With Citrulline Increases Renal Nitric Oxide in Young Spontaneously Hypertensive Rats and Has Long-Term Antihypertensive Effects Hypertension, December 1, 2007; 50(6): 1077 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li and H. E. Schellhorn New Developments and Novel Therapeutic Perspectives for Vitamin C J. Nutr., October 1, 2007; 137(10): 2171 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Podjarny, J. Bernheim, G. Hasdan, D. Karsh, G. Rashid, J. Green, B. Katz, and J. Bernheim Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1864 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hattori, S. Hattori, X. Wang, H. Satoh, N. Nakanishi, and K. Kasai Oral Administration of Tetrahydrobiopterin Slows the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Nurkiewicz and M. A. Boegehold High salt intake reduces endothelium-dependent dilation of mouse arterioles via superoxide anion generated from nitric oxide synthase Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1550 - R1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Paravicini and R. M. Touyz Redox signaling in hypertension Cardiovasc Res, July 15, 2006; 71(2): 247 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Forstermann and T. Munzel Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace Circulation, April 4, 2006; 113(13): 1708 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Wang, S.-H. Li, R. D. Weisel, P. W. M. Fedak, A. Hung, R.-K. Li, V. Rao, K. Hyland, W.-J. Cherng, L. Errett, et al. Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R299 - R304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Racasan, B. Braam, H. A. Koomans, and J. A. Joles Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon Am J Physiol Renal Physiol, April 1, 2005; 288(4): F626 - F636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Fortepiani and J. F. Reckelhoff Treatment with tetrahydrobiopterin reduces blood pressure in male SHR by reducing testosterone synthesis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R733 - R736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adler and H. Huang Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase Am J Physiol Renal Physiol, November 1, 2004; 287(5): F907 - F913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Podjarny, G. Hasdan, J. Bernheim, G. Rashid, J. Green, Z. Korzets, and J. Bernheim Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2223 - 2227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Alp and K. M. Channon Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 413 - 420. [Abstract] [Full Text]
|
|
|
|
|
|
J. Zhu, T. Mori, T. Huang, and J. H. Lombard Effect of high-salt diet on NO release and superoxide production in rat aorta Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H575 - H583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Mitchell, A. M. Dorrance, and R. C. Webb GTP cyclohydrolase 1 inhibition attenuates vasodilation and increases blood pressure in rats Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2165 - H2170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Zheng, X.-Q. Yang, K. J. Lookingland, G. D. Fink, C. Hesslinger, G. Kapatos, I. Kovesdi, and A. F. Chen Gene Transfer of Human Guanosine 5'-Triphosphate Cyclohydrolase I Restores Vascular Tetrahydrobiopterin Level and Endothelial Function in Low Renin Hypertension Circulation, September 9, 2003; 108(10): 1238 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ulker, D. McMaster, P. P. McKeown, and U. Bayraktutan Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation Cardiovasc Res, August 1, 2003; 59(2): 488 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Malo, F. Desjardins, J.-F. Tanguay, J.-C. Tardif, M. Carrier, and L. P. Perrault Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model Cardiovasc Res, August 1, 2003; 59(2): 501 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ulker, P. P. McKeown, and U. Bayraktutan Vitamins Reverse Endothelial Dysfunction Through Regulation of eNOS and NAD(P)H Oxidase Activities Hypertension, March 1, 2003; 41(3): 534 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Mitchell, A. M. Dorrance, and R. C. Webb GTP Cyclohydrolase 1 Downregulation Contributes to Glucocorticoid Hypertension in Rats Hypertension, March 1, 2003; 41(3): 669 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hattori, N. Nakanishi, K. Akimoto, M. Yoshida, and K. Kasai HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 176 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yang, N. Levens, J. N. Zhang, P. M. Vanhoutte, and M. Feletou Specific Potentiation of Endothelium-Dependent Contractions in SHR by Tetrahydrobiopterin Hypertension, January 1, 2003; 41(1): 136 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Tarpey Sepiapterin Treatment in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1519 - 1521. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Adler and H. Huang Impaired Regulation of Renal Oxygen Consumption in Spontaneously Hypertensive Rats J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1788 - 1794. [Abstract] [Full Text] [PDF]
|
|